Enter Note Done
Go to previous page in this tab
Session
  • Presentation | Poster - [In-Person Posters Sun] Drug Development: Human
  • Poster
  • The Oral P38a Kinase Inhibitor Neflamapimod Slows The Rate Of Clinical Worsening In Dementia With Lewy Bodies (DLB) [Board No. Sunday-0163]
  • Board no. Sunday-0163
    Set Timezone

John-Paul Taylor1, John Alam2, Stephen N. Gomperts3, Lawrence Honig4, NEILS PRINS, MD PHD5, Hui-May Chu6, Amanda Gardner2, Kelly Blackburn2, Charlotte Teunissen7, James Galvin8.
11.Translational and Clinical Research Institute and NIHR Newcastle Biomedical Research Centre, Newcastle University, Newcastle, United Kingdom, 2CervoMed, Inc., Boston, MA, USA, 3Department of Neurology, Massachusetts General Hospital, Boston, MA, USA, 44.Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Vagelos College of Physicians and Surgeons, New York, NY, USA, 5Brain Research Centre, Amsterdam, Netherlands, 6Anoixis Corporation, Natick, MA, USA, 7Neurochemistry Laboratory, Department of Laboratory Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands, 88.Comprehensive Center for Brain Health, Department of Neurology, University of Miami Miller School of Medicine, Boca Raton, FL, USA.
Types
Main Session